Navegar por autor "Campos Balea, Begoña"

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

2013- Afonso Afonso, Francisco Javier; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; [et al.]

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

2014- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; Alonso-Jaudenes Curbera, Guillermo [et al.]

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

2013- Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study

2011- Lazaro Quintela, Martín; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Campos Balea, Begoña; Senin Estor, Clara; [et al.]

Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer

2013- Candamio Folgar, Sonia; Gallardo Martín , Maria Elena; Campos Balea, Begoña; Álvarez Gómez, Elena; Quintero Aldana, Guillermo; [et al.]

Concurrent chemoradiation (CCHRT) for stage III non-small cell lung cancer (NSCLC): A phase II study from the galician lung cancer group

2013- Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Campos Balea, Begoña; López Vázquez, María Dolores [et al.]

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

2013- Pena Álvarez, Carolina; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Varela Ferreiro, Silvia; Campos Balea, Begoña [et al.]

Consistent benefit survival with cabazitaxel (CBZ) in metastatic castration resistant prostate cancer (mCRPC) in Spain: Updated results

2014- León Mateos, Luis Ángel; Campos Balea, Begoña

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study.

2011- Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Casal Rubio, Joaquín [et al.]

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Varela Ferreiro, Silvia; Campos Balea, Begoña; Barón Duarte, Francisco Javier [et al.]

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

2019- AGRASO BUSTO, SARA; VARELA POSE, VANESA; Fernández Nuñez, Natalia; Firvida Perez, Jose Luis; Santome, L.; [et al.]

Erlotinib as frontline treatment for elderly patients (p) with advanced non-squamous non-small cell lung cancer (nsnsclc): ggcp044/09 study

2012- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

2012- Afonso Afonso, Francisco Javier; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Fernández Montes, Ana; [et al.]

Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study

2012- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Álvarez Gómez, Elena; Mel Lorenzo, José Ramón [et al.]

Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP)

2011- Firvida Perez, Jose Luis; Fernández Montes, Ana; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)

2011- Fernández Calvo, Ovidio; García Mata, Jesús; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]

Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study

2015- Campos Balea, Begoña

GAPDH, YWHAZ, and RRN18S as control reference genes for gene expression studies on renal cell carcinoma (RCC) formaldehyde-fixed paraffin-embedded (FFPE) tissue samples

2011- Afonso Afonso, Francisco Javier; Valladares Ayerbes, Manuel; Antón Aparicio, Luis Miguel; Medina Villaamil, Vanessa; Fernández Calvo, Ovidio; [et al.]

Gefitinib efficacy in EGFR mutated non small cell lung cancer (NSCLC) patients based on type of mutation: A study from the galician lung cancer group

2013- Abdulkader Nallib, Ihab; Pena Álvarez, Carolina; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; [et al.]

Gemcitabine Plus Oral Vinorelbine as Salvage Therapy Treatment for Patients With Advanced Non-small-cell Lung Cancer and Squamous Histology - a Galician Lung Cancer Group Study (GGCP042/09) Grupo Galego De Cancro De Pulmon (GGCP)

2011- Firvida Perez, Jose Luis; Fernández Montes, Ana; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

Repositorio digital RUNA

Navegar por autor "Campos Balea, Begoña"

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study ﻿

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study. ﻿

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study ﻿

Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study ﻿

Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer ﻿

Concurrent chemoradiation (CCHRT) for stage III non-small cell lung cancer (NSCLC): A phase II study from the galician lung cancer group ﻿

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group ﻿

Consistent benefit survival with cabazitaxel (CBZ) in metastatic castration resistant prostate cancer (mCRPC) in Spain: Updated results ﻿

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study. ﻿

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study ﻿

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation ﻿

Erlotinib as frontline treatment for elderly patients (p) with advanced non-squamous non-small cell lung cancer (nsnsclc): ggcp044/09 study ﻿

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study ﻿

Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study ﻿

Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP) ﻿

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09) ﻿

Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study ﻿

GAPDH, YWHAZ, and RRN18S as control reference genes for gene expression studies on renal cell carcinoma (RCC) formaldehyde-fixed paraffin-embedded (FFPE) tissue samples ﻿

Gefitinib efficacy in EGFR mutated non small cell lung cancer (NSCLC) patients based on type of mutation: A study from the galician lung cancer group ﻿

Gemcitabine Plus Oral Vinorelbine as Salvage Therapy Treatment for Patients With Advanced Non-small-cell Lung Cancer and Squamous Histology - a Galician Lung Cancer Group Study (GGCP042/09) Grupo Galego De Cancro De Pulmon (GGCP) ﻿

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study

Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer

Concurrent chemoradiation (CCHRT) for stage III non-small cell lung cancer (NSCLC): A phase II study from the galician lung cancer group

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

Consistent benefit survival with cabazitaxel (CBZ) in metastatic castration resistant prostate cancer (mCRPC) in Spain: Updated results

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study.

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

Erlotinib as frontline treatment for elderly patients (p) with advanced non-squamous non-small cell lung cancer (nsnsclc): ggcp044/09 study

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study

Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP)

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)

Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study

GAPDH, YWHAZ, and RRN18S as control reference genes for gene expression studies on renal cell carcinoma (RCC) formaldehyde-fixed paraffin-embedded (FFPE) tissue samples

Gefitinib efficacy in EGFR mutated non small cell lung cancer (NSCLC) patients based on type of mutation: A study from the galician lung cancer group

Gemcitabine Plus Oral Vinorelbine as Salvage Therapy Treatment for Patients With Advanced Non-small-cell Lung Cancer and Squamous Histology - a Galician Lung Cancer Group Study (GGCP042/09) Grupo Galego De Cancro De Pulmon (GGCP)